MediciNova,Inc. Logo

MediciNova,Inc.

A clinical-stage biopharma company developing novel, small-molecule therapeutics.

4875 | T

Overview

Corporate Details

ISIN(s):
US58468P2065
LEI:
Country:
Japan
Address:
米国カリフォルニア州ラ・ホイヤ、スウィート300、エグゼクティブ・スクエア4275

Description

MediciNova, Inc. is a clinical-stage biopharmaceutical company that acquires and develops novel, small-molecule therapeutics. The company's late-stage pipeline focuses on addressing unmet medical needs in neurology, respiratory, and liver diseases. Key development programs include MN-166 (ibudilast) for neurological conditions, MN-001 (tipelukast) for fibrotic diseases such as liver fibrosis (NASH) and pulmonary fibrosis (IPF), and MN-221 for respiratory conditions including acute exacerbations of asthma and COPD.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-12 07:44
確認書
Japanese 8.4 KB
2025-09-12 07:43
半期報告書
Japanese 386.0 KB
2025-06-25 03:32
臨時報告書
Japanese 16.6 KB
2025-06-10 06:52
内部統制報告書
Japanese 51.3 KB
2025-06-10 06:51
確認書
Japanese 12.9 KB
2025-06-10 06:50
有価証券報告書
Japanese 3.0 MB
2024-09-11 04:32
確認書
Japanese 13.0 KB
2024-09-11 04:28
半期報告書
Japanese 436.9 KB
2024-06-17 09:06
臨時報告書
Japanese 15.4 KB
2024-06-13 05:03
確認書
Japanese 13.1 KB
2024-06-13 05:02
四半期報告書
Japanese 424.9 KB
2024-06-10 09:48
内部統制報告書
Japanese 51.4 KB
2024-06-10 09:46
有価証券報告書
Japanese 3.3 MB
2024-06-10 09:46
確認書
Japanese 12.9 KB
2023-12-12 06:01
確認書
Japanese 13.1 KB

Automate Your Workflow. Get a real-time feed of all MediciNova,Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MediciNova,Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MediciNova,Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.